Company News For Jun 20, 2018

• AT&T Inc.’s (T - Free Report) shares increased 0.6% after the company announced that there will be fewer commercials, personalized programming and smaller channel bundles following its acquisition of Time Warner
• Shares of Foundation Medicine, Inc. surged 28.5% on news that Swiss drug behemoth Roche was buying out the company for $2.4 billion
• Cotiviti Holdings, Inc.’s shares increased 10.3% after Verscend Technologies Inc agreed to buy the company for $4.9 billion
• Shares of Sarepta Therapeutics, Inc. (SRPT - Free Report) rose 36.8% after the company announced positive results from Phase 1/2 test on its microdystrophin gene therapy for Duchenne muscular dystrophy, or DMD

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>